Advanced search
Publication Cover
Expert Review of Clinical Immunology Volume 7, 2011 - Issue 2
Submit an article Journal homepage
181
Views
83
CrossRef citations to date
0
Altmetric
Review

Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention

Maureen McMahon Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA;[email protected]
,
Bevra H Hahn Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA; Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA
&
Brian J Skaggs Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA; Division of Rheumatology, Department of Medicine, David Geffen School of Medicine at the University of California Los Angeles, Los Angeles, CA, USA
Pages 227-241 | Published online: 10 Jan 2014

Citations (83)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Íñigo Rua-Figueroa Fernández de Larrinoa, María J Cuadrado Lozano, Carlos Marras Fernández-Cid, Tatiana Cobo Ibáñez, Tarek C Salman Monte, Mercedes Freire González, Francisco J Hidalgo Bermejo, Carmen San Román Gutiérrez & Josefina Cortés-Hernández. (2022) Preventing organ damage in systemic lupus erythematosus: the impact of early biological treatment. Expert Opinion on Biological Therapy 22:7, pages 821-829.
Read now
Tsung-Yu Tsai, Tsai-Hsien Lee, Hsiao-Han Wang, Ting-Hua Yang, I-Jing Chang & Yu-Chen Huang. (2021) Serum Homocysteine, Folate, and Vitamin B12 Levels in Patients with Systemic Lupus Erythematosus: A Meta-Analysis and Meta-Regression. Journal of the American College of Nutrition 40:5, pages 443-453.
Read now
John M Gemery, Andrew R Forauer & Eric K Hoffer. (2019) Activation of stem cell up-regulation/mobilization: a cardiovascular risk in both mice and humans with implications for liver disease, psoriasis and SLE. Vascular Health and Risk Management 15, pages 309-316.
Read now

Articles from other publishers (80)

Teresa Semalulu, Achieng Tago, Kevin Zhao & Konstantinos Tselios. (2023) Managing Cardiovascular Risk in Systemic Lupus Erythematosus: Considerations for the Clinician. ImmunoTargets and Therapy Volume 12, pages 175-186.
Crossref
Jacopo Ciaffi, Piero Ruscitti, Ilenia Di Cola, Viktoriya Pavlych, Noemi Italiano, Martina Gentile, Tom Huizinga, Jeska K. de Vries-Bouwstra, Francesco Ursini & Paola Cipriani. (2023) Whole body insulin sensitivity is increased in systemic sclerosis. PLOS ONE 18:3, pages e0283283.
Crossref
Natalia Bello, Kristin J Meyers, Jennifer Workman, Louise Hartley & Maureen McMahon. (2022) Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis. Lupus 32:3, pages 325-341.
Crossref
Chelsie Hurst, Maira Soto, Ernest R. Vina & Kathleen E. Rodgers. (2023) Renin-Angiotensin System-Modifying Antihypertensive Drugs Can Reduce the Risk of Cardiovascular Complications in Lupus: A Retrospective Cohort Study. The American Journal of Medicine 136:3, pages 284-293.e4.
Crossref
Karen Pesqueda-Cendejas, Melissa Rivera-Escoto, Mónica R. Meza-Meza, Bertha Campos-López, Isela Parra-Rojas, Margarita Montoya-Buelna & Ulises De la Cruz-Mosso. (2023) Nutritional Approaches to Modulate Cardiovascular Disease Risk in Systemic Lupus Erythematosus: A Literature Review. Nutrients 15:4, pages 1036.
Crossref
Aniruddha De. (2023) Left Ventricular Strain in Systemic Diseases. Journal of The Indian Academy of Echocardiography & Cardiovascular Imaging 0:0, pages 0.
Crossref
Marven G Cabling, Vaneet K Sandhu, Christina D Downey & Karina D Torralba. (2023) Cardiovascular disease and bone health in aging female rheumatic disease populations: A review. Women's Health 19, pages 174550572311552.
Crossref
Thomas Bieber, Eugen Feist, Alan D. Irvine, Masayoshi Harigai, Ewa Haladyj, Susan Ball, Walter Deberdt, Maher Issa, Susanne Grond & Peter C. Taylor. (2022) A Review of Safety Outcomes from Clinical Trials of Baricitinib in Rheumatology, Dermatology and COVID-19. Advances in Therapy 39:11, pages 4910-4960.
Crossref
Umesh Kumar Dhawan, Andreas Margraf, Maciej Lech & Manikandan Subramanian. (2022) Hypercholesterolemia promotes autoantibody production and a lupus‐like pathology via decreased DN ase‐mediated clearance of DNA . Journal of Cellular and Molecular Medicine 26:20, pages 5267-5276.
Crossref
Shivani Garg, Amish N. Raval, Karen E. Hansen, Weixiong Zhong, Yabing Huang, Maureen Smith, Sarah E. Panzer & Christie M. Bartels. (2022) Association of Renal Arteriosclerosis With Atherosclerotic Cardiovascular Disease Risk in Lupus Nephritis. Arthritis Care & Research 74:7, pages 1105-1112.
Crossref
Kristina Vollbach, Catharina Schuetz, Christian M. Hedrich, Fabian Speth, Kirsten Mönkemöller, Jürgen Brunner, Ulrich Neudorf, Christoph Rietschel, Anton Hospach, Tilmann Kallinich, Claas Hinze, Norbert Wagner, Burkhard Tönshoff, Lutz T. Weber, Kay Latta, Julia Thumfart, Martin Bald, Dagobert Wiemann, Hildegard Zappel, Klaus Tenbrock & Dieter Haffner. (2022) Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis – A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria. Frontiers in Pediatrics 10.
Crossref
Millan Whittier, Rocio Bautista Sanchez, Shilpa Arora & Augustine Mathew Manadan. (2022) Systemic Lupus Erythematosus and Antiphospholipid Antibody Syndrome as Risk Factors for Acute Coronary Syndrome in Young Patients. JCR: Journal of Clinical Rheumatology 28:3, pages 143-146.
Crossref
Matthew G Tayem, Linda Shahin, John Shook & Marc M Kesselman. (2022) A Review of Cardiac Manifestations in Patients With Systemic Lupus Erythematosus and Antiphospholipid Syndrome With Focus on Endocarditis. Cureus.
Crossref
Ehizogie Edigin, Pius Ehiremen Ojemolon, Precious Obehi Eseaton, Shakeel Jamal, Hafeez Shaka, Emmanuel Akuna, Iriagbonse Rotimi Asemota & Augustine Manadan. (2022) Systemic Sclerosis Is Associated With Increased Inpatient Mortality in Patients Admitted for Acute Coronary Syndrome. JCR: Journal of Clinical Rheumatology 28:1, pages e110-e117.
Crossref
Nicole K. Zagelbaum Ward, Carlos Linares-Koloffon, Alba Posligua, Liliya Gandrabur, Woo Young Kim, Kirk Sperber, Amy Wasserman & Julia Ash. (2020) Cardiac Manifestations of Systemic Lupus Erythematous: An Overview of the Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology and Treatment Options. Cardiology in Review 30:1, pages 38-43.
Crossref
Allison B. Reiss, Benna Jacob, Saba Ahmed, Steven E. Carsons & Joshua DeLeon. (2021) Understanding Accelerated Atherosclerosis in Systemic Lupus Erythematosus: Toward Better Treatment and Prevention. Inflammation 44:5, pages 1663-1682.
Crossref
Rune Matthiesen, Chris Lauber, Julio L. Sampaio, Neuza Domingues, Liliana Alves, Mathias J. Gerl, Manuel S. Almeida, Gustavo Rodrigues, Pedro Araújo Gonçalves, Jorge Ferreira, Cláudia Borbinha, João Pedro Marto, Marisa Neves, Frederico Batista, Miguel Viana-Baptista, Jose Alves, Kai Simons, Winchil L.C. Vaz & Otilia V. Vieira. (2021) Shotgun mass spectrometry-based lipid profiling identifies and distinguishes between chronic inflammatory diseases. EBioMedicine 70, pages 103504.
Crossref
Anna Łuczak, Rafał Małecki, Michał Kulus, Marta Madej, Ewa Szahidewicz-Krupska & Adrian Doroszko. (2021) Cardiovascular Risk and Endothelial Dysfunction in Primary Sjogren Syndrome Is Related to the Disease Activity. Nutrients 13:6, pages 2072.
Crossref
Jagan Sivakumaran, Paula Harvey, Ahmed Omar, Oshrat Tayer-Shifman, Murray B Urowitz, Dafna D Gladman, Nicole Anderson, Jiandong Su & Zahi Touma. (2021) Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus. Lupus Science & Medicine 8:1, pages e000448.
Crossref
George C Drosos, George Konstantonis, Petros P Sfikakis & Maria G Tektonidou. (2021) Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus. European Journal of Preventive Cardiology 28:3, pages 346-352.
Crossref
Paul Marczynski, Myriam Meineck, Ning Xia, Huige Li, Daniel Kraus, Wilfried Roth, Tamara Möckel, Simone Boedecker, Andreas Schwarting & Julia Weinmann-Menke. (2021) Vascular Inflammation and Dysfunction in Lupus-Prone Mice-IL-6 as Mediator of Disease Initiation. International Journal of Molecular Sciences 22:5, pages 2291.
Crossref
Gabriela Pocovi-Gerardino, María Correa-Rodríguez, José-Luis Callejas-Rubio, Raquel Ríos-Fernández, María Martín-Amada, María-Gracia Cruz-Caparros, Blanca Rueda-Medina & Norberto Ortego-Centeno. (2021) Beneficial effect of Mediterranean diet on disease activity and cardiovascular risk in systemic lupus erythematosus patients: a cross-sectional study. Rheumatology 60:1, pages 160-169.
Crossref
Stephanie Saeli, Tanmayee Bichile, Payal Thakkar & Susan Manzi. 2021. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 415 426 .
Brygida Przywara-Chowaniec, Dominika Blachut, Jan Harpula, Marcin Bereś, Agnieszka Nowak & Ewa Nowalany-Kozielska. (2020) Systemic Lupus Erythematosus, Its Impact on Selected Cardiovascular Risk Factors, and Correlation with Duration of Illness: A Pilot Study. Cardiology Research and Practice 2020, pages 1-8.
Crossref
Leslie Cho, Melinda Davis, Islam Elgendy, Kelly Epps, Kathryn J. Lindley, Puja K. Mehta, Erin D. Michos, Margo Minissian, Carl Pepine, Viola Vaccarino & Annabelle Santos Volgman. (2020) Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women. Journal of the American College of Cardiology 75:20, pages 2602-2618.
Crossref
Anna Łuczak, Marta Madej, Agata Kasprzyk & Adrian Doroszko. (2020) Role of the eNOS Uncoupling and the Nitric Oxide Metabolic Pathway in the Pathogenesis of Autoimmune Rheumatic Diseases. Oxidative Medicine and Cellular Longevity 2020, pages 1-15.
Crossref
Gabriela Pocovi-Gerardino, Maria Correa-Rodríguez, José-Luis Callejas Rubio, Raquel Ríos Fernández, María Martín Amada, María-Gracia Cruz Caparros, Blanca Rueda-Medina & Norberto Ortego-Centeno. (2019) The Relationships of High-Sensitivity C-Reactive Protein and Homocysteine Levels With Disease Activity, Damage Accrual, and Cardiovascular Risk in Systemic Lupus Erythematosus. Biological Research For Nursing 22:2, pages 169-177.
Crossref
George C Drosos, George Konstantonis, Petros P Sfikakis & Maria G Tektonidou. (2020) Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus. European Journal of Preventive Cardiology, pages 204748732090665.
Crossref
S Li, T Gong, Y Peng, K M Nieman & D T Gilbertson. (2019) Prevalence and incidence of systemic lupus erythematosus and associated outcomes in the 2009–2016 US Medicare population. Lupus 29:1, pages 15-26.
Crossref
Dominique P V de Kleijn, Suet Yen Chong, Xiaoyuan Wang, Siti Maryam J M Yatim, Anna-Marie Fairhurst, Flora Vernooij, Olga Zharkova, Mark Y Chan, Roger S Y Foo, Leo Timmers, Carolyn S P Lam & Jiong-Wei Wang. (2019) Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction. Cardiovascular Research 115:12, pages 1791-1803.
Crossref
Eliel Marcio Pedro, Lorena Flor da Rosa Franchi Santos, Bruna Miglioranza Scavuzzi, Tatiana Mayumi Veiga Iriyoda, Tiago Severo Peixe, Marcell Alysson Batiste Lozovoy, Edna Maria Vissoci Reiche, Isaias Dichi, Andréa Name Colado Simão & Maria Josefa Santos. (2019) Trace Elements Associated with Systemic Lupus Erythematosus and Insulin Resistance. Biological Trace Element Research 191:1, pages 34-44.
Crossref
Gantsetseg Tumurkhuu, Erica Montano & Caroline Jefferies. (2019) Innate Immune Dysregulation in the Development of Cardiovascular Disease in Lupus. Current Rheumatology Reports 21:9.
Crossref
Nearmeen M. Rashad, Reem M. Allam, Dina Said, Ayman E. Ali, Nesreen M. Mohy & Hala G. Abomandour. (2019) Influence of +299G>A and +62G˃A resistin gene promoter variants on cardiovascular risk in Egyptian women with systemic lupus erythematosus. The Egyptian Rheumatologist 41:3, pages 215-220.
Crossref
Sung Ahn, Juyoung Yoo, Seung Jung, Jason Song, Yong-Beom Park & Sang-Won Lee. (2019) Comparison of the Clinical Implications among Five Different Nutritional Indices in Patients with Lupus Nephritis. Nutrients 11:7, pages 1456.
Crossref
Sonia Henry, Rachel Bond, Stacey Rosen, Cindy Grines & Jennifer Mieres. (2019) Challenges in Cardiovascular Risk Prediction and Stratification in Women. Cardiovascular Innovations and Applications 3:4.
Crossref
Serena Fasano, Domenico Paolo Emanuele Margiotta, Luciana Pierro, Luca Navarini, Antonella Riccardi, Antonella Afeltra & Gabriele Valentini. (2018) Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study. Clinical Rheumatology 38:2, pages 457-463.
Crossref
Aliaa El-Hady, Soha Sennara, Yasmin Mosaad & Nisreen Mahmoud. (2019) Serum ferritin, transferrin and metabolic syndrome are risk factors for subclinical atherosclerosis in Egyptian women with systemic lupus erythematosus (SLE). The Egyptian Rheumatologist 41:1, pages 35-40.
Crossref
Jyoti Bakshi, Beatriz Tejera Segura, Christopher Wincup & Anisur Rahman. (2017) Unmet Needs in the Pathogenesis and Treatment of Systemic Lupus Erythematosus. Clinical Reviews in Allergy & Immunology 55:3, pages 352-367.
Crossref
Reza Mohammadian, Ali Tarighatnia, Mehran Naghibi, Evin Koleini & Nader D. Nader. (2018) Vertebrobasilar Artery Stroke as the Heralding Sign of Systemic Lupus Erythematosus. Journal of Stroke and Cerebrovascular Diseases 27:5, pages e80-e85.
Crossref
Serena Fasano, Domenico Paolo Margiotta, Roberta Gualtierotti, Ada Corrado, Onorina Berardicurti, Daniela Iacono, Luciana Pierro, Antonella Riccardi, Roberto Giacomelli, Francesco Paolo Cantatore, Pier Luigi Meroni, Antonella Afeltra & Gabriele Valentini. (2018) The incidence of cardiovascular events in Italian patients with systemic lupus erythematosus is lower than in North European and American cohorts. Medicine 97:15, pages e0370.
Crossref
F. Caravaca-Fontán & M. Praga. (2018) Enfermedad cardiovascular en la nefropatía lúpica: un riesgo infraestimado. Hipertensión y Riesgo Vascular 35:2, pages 51-53.
Crossref
Lora J. Kasselman, Nicholas A. Vernice, Joshua DeLeon & Allison B. Reiss. (2018) The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity. Atherosclerosis 271, pages 203-213.
Crossref
Maryam Tanhapour, Ali Miri, Asad Vaisi-Raygani, Fariborz Bahrehmand, Amir Kiani, Zohreh Rahimi, Tayebeh Pourmotabbed & Ebrahim Shakiba. (2017) Synergism between apolipoprotein E Ɛ4 allele and paraoxonase (PON1) 55-M allele is associated with risk of systemic lupus erythematosus. Clinical Rheumatology 37:4, pages 971-977.
Crossref
L F da Rosa Franchi Santos, N P Stadtlober, L G Costa Dall'Aqua, B M Scavuzzi, P M Guimarães, T Flauzino, M A Batisti Lozovoy, T V Mayumi Iriyoda, E M Vissoci Reiche, I Dichi, M Maes & A Colado Simão. (2018) Increased adhesion molecule levels in systemic lupus erythematosus: relationships with severity of illness, autoimmunity, metabolic syndrome and cortisol levels. Lupus 27:3, pages 380-388.
Crossref
Daniel J. Wallace. 2018. Biologic and Systemic Agents in Dermatology. Biologic and Systemic Agents in Dermatology 377 390 .
S. Chandrashekara, Sachin Vithalrao Dhote & K. R. Anupama. (2017) The Differential Influence of Immunological Process of Autoimmune Disease on Lipid Metabolism: A Study on RA and SLE. Indian Journal of Clinical Biochemistry.
Crossref
M C Soh, C Nelson-Piercy, M Westgren, L McCowan & D Pasupathy. (2017) Do adverse pregnancy outcomes contribute to accelerated cardiovascular events seen in young women with systemic lupus erythematosus?. Lupus 26:13, pages 1351-1367.
Crossref
Wei-Syun Hu, Peramaiyan Rajendran, Bor-Show Tzang, Yu-Lan Yeh, Chia-Yao Shen, Ray-Jade Chen, Tsung-Jung Ho, Viswanadha Vijaya Padma, Yi-Hsing Chen & Chih-Yang Huang. (2017) Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice. PLOS ONE 12:9, pages e0185098.
Crossref
Umair Akbar, Melissa Yang, Divya Kurian & Chandra Mohan. (2017) Omega-3 Fatty Acids in Rheumatic Diseases. JCR: Journal of Clinical Rheumatology 23:6, pages 330-339.
Crossref
Sara Croca & Anisur Rahman. (2017) Atherosclerosis in systemic lupus erythematosus. Best Practice & Research Clinical Rheumatology 31:3, pages 364-372.
Crossref
Eugeniusz Hrycek, Iwona Banasiewicz‐Szkróbka, Aleksander Żurakowski, Paweł Buszman & Antoni Hrycek. 2017. Lupus. Lupus.
Roy O. Mathew, Sripal Bangalore, Michael P. Lavelle, Patricia A. Pellikka, Mandeep S. Sidhu, William E. Boden & Arif Asif. (2017) Diagnosis and management of atherosclerotic cardiovascular disease in chronic kidney disease: a review. Kidney International 91:4, pages 797-807.
Crossref
Nermeen Khairy, Yasser Ezzat, Nahla Naeem, Radwa Taha & Rasha Wesam. (2017) Atherosclerosis biomarkers in female systemic lupus erythematosus patients with and without cardiovascular diseases. The Egyptian Rheumatologist 39:1, pages 7-12.
Crossref
S. Gruber, D. Tsiantoulas & C.J. Binder. 2017. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases. The Heart in Rheumatic, Autoimmune and Inflammatory Diseases 65 89 .
Hannan Al-RayesGhaleb HuraibSaeed JulkhufMisbahul ArfinMohammad TariqAbdulrahman Al-Asmari. (2016) Apolipoprotein E Gene Polymorphisms in Saudi Patients with Systemic Lupus Erythematosus. Clinical Medicine Insights: Arthritis and Musculoskeletal Disorders 9, pages CMAMD.S38090.
Crossref
Erin C Carruthers, Hyon K Choi, Eric C Sayre & J Antonio Aviña-Zubieta. (2016) Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study. Annals of the Rheumatic Diseases 75:1, pages 110-116.
Crossref
Susan Manzi. 2016. Systemic Lupus Erythematosus. Systemic Lupus Erythematosus 373 381 .
J. Antonio Aviña-Zubieta, Kateryna Vostretsova, Mary A. De Vera, Eric C. Sayre & Hyon K. Choi. (2015) The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: A general population-based study. Seminars in Arthritis and Rheumatism 45:2, pages 195-201.
Crossref
Sharan K. Rai, Hyon K. Choi, Eric C. Sayre & J. Antonio Aviña-Zubieta. (2015) Risk of myocardial infarction and ischaemic stroke in adults with polymyositis and dermatomyositis: a general population-based study. Rheumatology, pages kev336.
Crossref
Stacey E. Rosen, Sonia Henry, Rachel Bond, Camille Pearte & Jennifer H. Mieres. (2015) Sex-Specific Disparities in Risk Factors for Coronary Heart Disease. Current Atherosclerosis Reports 17:8.
Crossref
S. Fadda, H. Nassar, S.M. Gamal & H. Al-azizi. (2014) Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indicesSubklinische Atherosklerose bei Patienten mit systemischem Lupus erythematodes und deren Zusammenhang zwischen Krankheitsaktivität und Schweregradindizes. Zeitschrift für Rheumatologie 74:6, pages 529-532.
Crossref
Marieke C.S. BoshuizenMenno P.J. de Winther. (2015) Interferons as Essential Modulators of Atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 35:7, pages 1579-1588.
Crossref
Judit Marsillach, Jessica O. Becker, Tomas Vaisar, Bevra H. Hahn, John D. Brunzell, Clement E. Furlong, Ian H. de Boer, Maureen A. McMahon & Andrew N. Hoofnagle. (2015) Paraoxonase-3 Is Depleted from the High-Density Lipoproteins of Autoimmune Disease Patients with Subclinical Atherosclerosis. Journal of Proteome Research 14:5, pages 2046-2054.
Crossref
Hala A. Raafat, Samar M. Fawzy & Hussein S. El Fishawy. (2015) Intima-media thickness in secondary anti-phospholipid syndrome patients: Impact of disease activity. The Egyptian Rheumatologist 37:2, pages 55-60.
Crossref
Eman Baraka, Mounir El Dein, Hesham Farouk & Youmna El Moutaz. (2015) Hyperhomocysteinemia and metabolic syndrome are risk factors for sub-clinical atherosclerosis in women with systemic lupus erythematosus. The Egyptian Rheumatologist 37:2, pages 67-74.
Crossref
Paul Kurlansky. (2015) Inflammation: The classic double-edged sword. The Journal of Thoracic and Cardiovascular Surgery 149:3, pages 866-868.
Crossref
Lisa Carole Loram, Melissa Elizabeth Culp, Erin Corey Connolly-Strong & Sheila Sturgill-Koszycki. (2014) Melanocortin Peptides: Potential Targets in Systemic Lupus Erythematosus. Inflammation 38:1, pages 260-271.
Crossref
Daniel J. Wallace. 2015. Rheumatology. Rheumatology 1099 1106 .
Elisheva Pokroy-Shapira, Ilana Gelernter & Yair Molad. (2014) Evolution of chronic kidney disease in patients with systemic lupus erythematosus over a long-period follow-up: a single-center inception cohort study. Clinical Rheumatology 33:5, pages 649-657.
Crossref
M. M. Radwan, D. El-Lebedy, R. Fouda, E. Elsorougy & D. Fakhry. (2013) Anti-apolipoprotein A-1 antibodies and carotid intima–media thickness in Egyptian women with systemic lupus erythematosus. Clinical Rheumatology 33:4, pages 493-498.
Crossref
Jenny Amaya-Amaya, Laura Montoya-Sánchez & Adriana Rojas-Villarraga. (2014) Cardiovascular Involvement in Autoimmune Diseases. BioMed Research International 2014, pages 1-31.
Crossref
Francesco VioliPasquale PignatelliClaudio PignataAlessandro PlebaniPaolo RossiValerio SanguigniRoberto CarnevaleAnnarosa SoresinaAndrea FinocchiEmilia CirilloElisa CatascaFrancesco AngelicoLorenzo Loffredo. (2013) Reduced Atherosclerotic Burden in Subjects With Genetically Determined Low Oxidative Stress. Arteriosclerosis, Thrombosis, and Vascular Biology 33:2, pages 406-412.
Crossref
Jenny Amaya-Amaya, Juan Camilo Sarmiento-Monroy, Julián Caro-Moreno, Nicolás Molano-González, Rubén D. Mantilla, Adriana Rojas-Villarraga & Juan-Manuel Anaya. (2013) Cardiovascular Disease in Latin American Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study and a Systematic Review. Autoimmune Diseases 2013, pages 1-20.
Crossref
Zheng Liu & Anne Davidson. (2012) Taming lupus—a new understanding of pathogenesis is leading to clinical advances. Nature Medicine 18:6, pages 871-882.
Crossref
Bevra H. Hahn, Maureen A. McMahon, Alan Wilkinson, W. Dean Wallace, David I. Daikh, John D. FitzGerald, George A. Karpouzas, Joan T. Merrill, Daniel J. Wallace, Jinoos Yazdany, Rosalind Ramsey‐Goldman, Karandeep Singh, Mazdak Khalighi, Soo‐In Choi, Maneesh Gogia, Suzanne Kafaja, Mohammad Kamgar, Christine Lau, William J. Martin, Sefali Parikh, Justin Peng, Anjay Rastogi, Weiling Chen & Jennifer M. Grossman. (2012) American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care & Research 64:6, pages 797-808.
Crossref
Haiyan Tu, Qi Li, Shilong Xiang, Hong Jiang, Youying Mao, Zhangfei Shou & Jianghua Chen. (2012) Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: The potential role for regulatory T cells. Atherosclerosis 222:1, pages 29-33.
Crossref
Monika Edelbauer, Sudhir Kshirsagar, Magdalena Riedl, Heiko Billing, Burkhard Tönshoff, Dieter Haffner, Jörg Dötsch, Gottfried Wechselberger, Lutz T. Weber & Elisabeth Steichen-Gersdorf. (2011) Soluble VEGF receptor 1 promotes endothelial injury in children and adolescents with lupus nephritis. Pediatric Nephrology 27:5, pages 793-800.
Crossref
Eugene Joseph Kucharz. (2012) Chronic inflammation-enhanced atherosclerosis: Can we consider it as a new clinical syndrome?. Medical Hypotheses 78:3, pages 396-397.
Crossref
Yang SongHua ShenDominik SchentenPeiying ShanPatty J. LeeDaniel R. Goldstein. (2012) Aging Enhances the Basal Production of IL-6 and CCL2 in Vascular Smooth Muscle Cells. Arteriosclerosis, Thrombosis, and Vascular Biology 32:1, pages 103-109.
Crossref
Athina Pyrpasopoulou, Sofia Chatzimichailidou & Spyros Aslanidis. (2012) Vascular Disease in Systemic Lupus Erythematosus. Autoimmune Diseases 2012, pages 1-4.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.